Michael Yang
Net worth: 918 395 $ as of 2026-05-30
Net worth: 918 395 $ as of 2026-05-30
Michael J.
Yang currently works at Ionis Pharmaceuticals, Inc., as Independent Director from 2023, Pacira Biosciences, Inc., as Independent Director from 2023, and ARTIS Ventures Management LP, as Operating Partner.
Mr. Yang also formerly worked at ViaCyte, Inc., as President, Chief Executive Officer & Director from 2021 to 2022, Akcea Therapeutics, Inc., as Director in 2020, Johnson & Johnson, as President, ACADIA Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP from 2017 to 2021, Ortho Biotech, Inc., as Vice President-Sales & Marketing, Veridex LLC, as General Manager, Therakos, Inc., as General Manager, Janssen Biotech, Inc., as President, and Janssen Pharmaceuticals, Inc., as President-Immunology from 2013 to 2017.
Mr. Yang received his undergraduate degree from San Diego State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 7,940 ( 0% ) | 607 410 $ | 2026-05-30 | |
| 2026-04-16 | 13,393 ( 0.03% ) | 310 985 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Director/Board Member | 2023-10-09 |
| IONIS PHARMACEUTICALS, INC. | Director/Board Member | 2023-12-13 |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Private Equity Investor | - |
| Companies | Position | End |
|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Chief Executive Officer | 2022-09-30 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 2021-01-28 |
| AKCEA THERAPEUTICS, INC. | Director/Board Member | 2020-11-30 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 2017-02-28 |
| JOHNSON & JOHNSON | President | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Ortho Biotech, Inc. | |
Veridex LLC
Veridex LLC Medical SpecialtiesHealth Technology Supplies vitro diagnostic oncology products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therakos, Inc.
Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Finance |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions